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A cholera outbreak in Terengganu, Malaysia, in 
November 2009 was caused by 2 El Tor Vibrio cholerae 
variants resistant to typical antimicrobial drugs. Evidence 
of replacement of treatable V. cholerae infection in the 
region with antimicrobial-resistant strains calls for increased 
surveillance and prevention measures.
V
ibrio cholerae, the causative agent of cholera, is 
endemic in many parts of the world, especially in 
countries that lack clean water supplies and adequate 
public health facilities (1). In Malaysia, cholera outbreaks 
caused by the El Tor O1 V. cholerae serogroup occur 
periodically, cases from the 0139 serogroup occur 
sporadically, and the non–O1/non–O139 V. cholerae 
serogroup has not been implicated in any major outbreak 
(2–4). Contaminated drinking water, cooked food, 
and raw or undercooked seafood served as vehicles of 
transmission in Malaysia (5).
The Study
In November 2009, a cholera outbreak occurred in 
Terengganu, Peninsular Malaysia. The outbreak began 
in the capital, Kuala Terengganu, and spread to several 
districts within a week. Approximately 400 persons 
were hospitalized for treatment of acute diarrhea and its 
complications during the outbreak period. One death 
occurred before the local health authorities declared an 
outbreak. Five ice factories, 2 ﬁ  sh cracker factories, and 
several restaurants and street cart food vendors were 
ordered closed because they were suspected of being 
possible sources of the outbreak (Ministry of Health, 
Malaysia, unpub. data).
For this study, 75 rectal swab samples, collected 
from patients admitted to Hospital Sultanah Nur Zahirah 
in Kuala Terengganu who had acute diarrhea during the 
outbreak period, were available for analysis. In addition, 60 
environmental samples (6 water samples, 54 environmental 
swab samples) were collected from 2 of the ice factories 
(factories A and B) in Kuala Terengganu by the Terengganu 
State Department of Health during the outbreak period 
and were provided to us for analysis. Environmental swab 
samples were obtained from several areas within the ice-
making factories. The rectal swab and environmental samples 
were enriched overnight in alkaline-buffered peptone water, 
pH 8.6 (Oxoid, Basingstoke, UK) and cultured on thiosulfate 
citrate-bile salts-sucrose agar (Oxoid). The presumptive 
colonies were subjected to conventional biochemical tests, 
such as string, salt tolerance, Voges-Proskauer, lysine iron 
agar, Kliger iron agar, and arginine dihydrolase testing. PCRs 
targeting ompW, hlyA, rfb, ctxA, toxR, tcpI, rtxC, rstR, and 
tcpA genes as described (6,7) were run in parallel to conﬁ  rm 
and characterize V. cholerae isolates. Template DNA was 
also prepared directly from the water samples as described 
(6) for detection of viable but nonculturable V. cholerae and 
its virulence genes.
Antimicrobial drug susceptibility of the conﬁ  rmed 
V. cholerae isolates was determined by the disk diffusion 
method according to Clinical and Laboratory Standards 
Institute guidelines (8). Six antimicrobial agents (Oxoid) 
were used: ampicillin (10 μg), chloramphenicol (30 μg), 
ciproﬂ  oxacin (5 μg), trimethoprim/sulfamethoxazole (25 
μg), erythromycin (15 μg), and tetracycline (30 μg). To 
determine the genetic relatedness of the isolates, pulsed-
ﬁ  eld gel electrophoresis (PFGE) was performed according 
to the established PulseNet protocol (9) and analyzed with 
BioNumerics 6.0 (Applied Maths, Kortrijk, Belgium); ctxB 
genotyping was also performed as described (10).
On the basis of conventional biochemical tests and PCR, 
37 isolates from the rectal swab samples and 1 isolate from 
the washroom swab sample of ice factory B were conﬁ  rmed 
as V. cholerae, showing an isolation rate of 48.0% for the 
clinical samples and 1.9% for the environmental samples. 
In addition, the 37 clinical isolates were identiﬁ  ed as El 
Tor O1 on the basis of Voges-Proskauer tests and were 
positive for hlyAEl, tcpAEl, rstREl, rtxC, and rfbO1 genes. 
The ctxA, toxR, and tcpI genes were present in all of the 
clinical isolates. The isolate from the restroom specimen 
of factory B was identiﬁ   ed as a non–O1/non–O139 V. 
cholerae strain that had hlyAEl, rstREl, and toxR genes. This 
ﬁ  nding indicated that this isolate was likely not related to 
the outbreak in question. No ampliﬁ  cation of V. cholerae–
speciﬁ  c genes was observed for the DNA extracted directly 
from the water samples.
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cholerae isolate was sensitive to all the antimicrobial 
agents tested, the 37 clinical O1 V. cholerae isolates were 
resistant to ampicillin, trimethoprim/sulfamethoxazole, 
erythromycin, and tetracycline. In Malaysia, tetracycline 
generally has been considered the drug of choice for cholera 
treatment; however, it has been replaced by erythromycin 
because the number of tetracycline-resistant strains has 
increased since a 1992 outbreak in the state of Kelantan 
(11). The emergence of erythromycin-resistant isolates in 
this outbreak will likely contribute to decreased efﬁ  cacy of 
erythromycin.
PFGE of NotI-digested chromosomal DNA from 
all of the human isolates resulted in 1 pulsotype with 24 
fragments (≈30 kb to ≈370 kb); the environmental isolate 
showed a distinct pulsotype (F = 0.83) (Figure 1). PFGE 
was repeated 2× with identical results. In addition, the 
pulsotype of the clinical isolates in this study was identical 
to the pulsotype of an O1 isolate (123/08) from a cholera 
patient in Kuala Lumpur in 2008 (Figure 1) (12). Isolate 
123/08 also showed identical antibiograms with the 
Terengganu O1 outbreak isolates. This ﬁ  nding suggests 
that isolate 123/08 and the Terengganu 2009 O1 outbreak 
isolates were possibly linked.
Several ctxB alleles have been identiﬁ  ed among O1 V. 
cholerae strains on the basis of a few point mutations: 1) 
classical and El Tor, US Gulf Coast (39His, 46Phe, 68Tyr); 
2) El Tor, Australia (39His, 46Leu, 68Tyr); and 3) El Tor, 
seventh pandemic, and El Tor, Latin American epidemic 
(39Tyr, 46Phe, 68Ile) (10). Of the 37 isolates, 33 were 
classiﬁ  ed as genotype 3 on the basis of multiple sequence 
alignments of ctxB (10). Similarly, our previous multilocus 
sequence typing study (2) subtyped isolate 123/08 as an El 
Tor biotype characterized by the ctxB3 gene (Figure 2). We 
postulate that this particular clone has reemerged since its 
isolation in Kuala Lumpur in 2008 and was likely linked to 
the 2009 Terengganu outbreak.
Four of the 37 clinical isolates showed amino acid 
substitutions Tyr39His and Ile68Thr (Figure 2) and were 
classiﬁ  ed as genotype 1. Genotype 1 strains that carry both 
classical and El Tor rstR allele have been detected in Asian 
and African countries since the 1990s (13). In 2001, El 
Tor variant strains that harbored rstREl/ctxB1 superseded 
the typical El Tor strains in Bangladesh and other Asian 
countries. Since 2007, outbreaks in Vietnam and Thailand 
have been mainly caused by El Tor variant strains (7,14). 
Ang et al. (3) reported that El Tor variant strains could 
have emerged earlier in Malaysia because 1 such strain was 
responsible for the 2000 outbreak in Kelantan. In contrast 
to neighboring countries, our current study indicates that 
the El Tor strains have not been replaced by El Tor variant 
strains in Malaysia; typical El Tor strains are still found in 
this country. In our current study, the isolates could not be 
differentiated by PFGE, although they belonged to 2 ctxB 
genotypes. This ﬁ  nding might be attributed to the genetic 
events resulting in the transfer of the different ctxB alleles 
among the V. cholerae populations in Malaysia or with the 
strains from neighboring countries.
Conclusions
The 2009 cholera outbreak in Terengganu was 
controlled in late November; 187 cases and 1 death were 
conﬁ  rmed (www.myhealth.gov.my/myhealth). We found 
no evidence of an association between 2 ice factories 
considered as possible sources of infection and the 
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Figure 1. NotI-pulsed-ﬁ   eld gel electrophoresis proﬁ  les  of  Vibrio 
cholerae isolated during the outbreak, Terengganu, Malaysia, 2009. 
Lane M: XbaI-digested Salmonella enterica serovar Braenderup 
H9812 as DNA standard; lanes 1–7 and 9–12: isolates of El Tor 
O1 serogroup (rectal swab); lane 8: isolate of non–O1/non–O139 
serogroup (swab from ice factory); lane 13: El Tor O1 V. cholerae 
isolated in 2008 (Kuala Lumpur).
Figure 2. Amino acid sequence alignment of the ctxB subunit of 
representative Vibrio cholerae isolates from the cholera outbreak, 
Terengganu, Malaysia, 2009. El Tor O1 N16961 (ctxB3) was used 
as the reference strain in the alignment. Identical amino acid 
residues are indicated by dots. Two genotypes (1,3) were observed 
in the outbreak strains.V. cholerae Genotypes
outbreak. The health authorities later ruled out the other 
ice factories, ﬁ  sh cracker factories, and eateries suspected 
of being sources and were unable to trace the source of the 
outbreak.
Two genotypes (ctxB1 and ctxB3) of the El Tor O1 
V. cholerae serogroup with identical pulsotypes were 
likely responsible for the cholera outbreak in Terengganu 
in late 2009. Our ﬁ  ndings support the need for increased 
surveillance in the region to document the prevalence of 
such strains. Preventive activities such as water sanitation, 
public education on proper food handling, and personal 
cleanliness are crucial to reduce the risk of spread of 
cholera.
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